Entrez Id: |
753 |
Gene Symbol: |
LDLRAD4 |
LDLRAD4
|
low density lipoprotein receptor class A domain containing 4
|
0.769 |
0.231 |
0.62 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
4781 |
Gene Symbol: |
NFIB |
NFIB
|
nuclear factor I B
|
0.573 |
0.654 |
1.00 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
4507 |
Gene Symbol: |
MTAP |
MTAP
|
methylthioadenosine phosphorylase
|
0.514 |
0.731 |
7.6E-08 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
2113 |
Gene Symbol: |
ETS1 |
ETS1
|
ETS proto-oncogene 1, transcription factor
|
0.444 |
0.731 |
0.78 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
2104 |
Gene Symbol: |
ESRRG |
ESRRG
|
estrogen related receptor gamma
|
0.621 |
0.692 |
7.1E-02 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
2070 |
Gene Symbol: |
EYA4 |
EYA4
|
EYA transcriptional coactivator and phosphatase 4
|
0.604 |
0.615 |
4.9E-02 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
200403 |
Gene Symbol: |
VWA3B |
VWA3B
|
von Willebrand factor A domain containing 3B
|
0.729 |
0.154 |
9.7E-28 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
20 |
Gene Symbol: |
ABCA2 |
ABCA2
|
ATP binding cassette subfamily A member 2
|
0.670 |
0.615 |
1.00 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
148534 |
Gene Symbol: |
TLCD4 |
TLCD4
|
TLC domain containing 4
|
0.931 |
0.038 |
0.26 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
1415 |
Gene Symbol: |
CRYBB2 |
CRYBB2
|
crystallin beta B2
|
0.623 |
0.462 |
0.39 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
1305 |
Gene Symbol: |
COL13A1 |
COL13A1
|
collagen type XIII alpha 1 chain
|
0.608 |
0.654 |
3.7E-14 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
11037 |
Gene Symbol: |
STON1 |
STON1
|
stonin 1
|
0.729 |
0.308 |
1.5E-11 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
10659 |
Gene Symbol: |
CELF2 |
CELF2
|
CUGBP Elav-like family member 2
|
0.628 |
0.692 |
1.00 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
1060 |
Gene Symbol: |
CENPC |
CENPC
|
centromere protein C
|
0.743 |
0.538 |
7.4E-05 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
105 |
Gene Symbol: |
ADARB2 |
ADARB2
|
adenosine deaminase RNA specific B2 (inactive)
|
0.716 |
0.308 |
0.86 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
22871 |
Gene Symbol: |
NLGN1 |
NLGN1
|
neuroligin 1
|
0.705 |
0.385 |
0.85 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
22920 |
Gene Symbol: |
KIFAP3 |
KIFAP3
|
kinesin associated protein 3
|
0.760 |
0.346 |
1.6E-05 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
387890 |
Gene Symbol: |
TMEM233 |
TMEM233
|
transmembrane protein 233
|
1.000 |
|
9.1E-02 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
3660 |
Gene Symbol: |
IRF2 |
IRF2
|
interferon regulatory factor 2
|
0.575 |
0.769 |
0.80 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
30844 |
Gene Symbol: |
EHD4 |
EHD4
|
EH domain containing 4
|
0.931 |
0.115 |
4.2E-05 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
29119 |
Gene Symbol: |
CTNNA3 |
CTNNA3
|
catenin alpha 3
|
0.612 |
0.692 |
1.0E-12 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
STON1-GTF2A1L
|
STON1-GTF2A1L readthrough
|
0.682 |
0.385 |
1.5E-22 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
284217 |
Gene Symbol: |
LAMA1 |
LAMA1
|
laminin subunit alpha 1
|
0.582 |
0.808 |
3.2E-32 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
27165 |
Gene Symbol: |
GLS2 |
GLS2
|
glutaminase 2
|
0.597 |
0.538 |
1.3E-10 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |
Entrez Id: |
23671 |
Gene Symbol: |
TMEFF2 |
TMEFF2
|
transmembrane protein with EGF like and two follistatin like domains 2
|
0.619 |
0.500 |
7.4E-05 |
Adverse effects, not elsewhere classified
|
disease |
0.100 |
None
|
1.000 |
1 |
1 |
2019 |
2019 |